Lupin gets additional time to set up unit at Nagpur SEZ

19 May 2015 Evaluate

Pharma major Lupin has been granted an extension to set up its state-of-the-art formulation manufacturing unit at the MIHAN Special Economic Zone (SEZ) in Nagpur from the Commerce Ministry. However, a final call on the matter is yet to be taken by the Board of Approval (BoA) for SEZs.

Lupin had sought the extension on the grounds that it is yet to receive approvals from the US Food and Drug Administration (USFDA) for drugs that are to be produced at the unit. The company received the letter-of-permission (LoP) for setting up its unit in the MIHAN SEZ in April 2012, but has not been able to start commercial operations.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.

Lupin Share Price

2076.70 21.65 (1.05%)
11-Dec-2025 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.15
Dr. Reddys Lab 1273.95
Cipla 1508.50
Zydus Lifesciences 924.75
Lupin 2076.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×